TSC1 and neoplasm: Whereas wild-type TAMs display pro-inflammatory and pro-angiogenic transcriptional profiles, TSC1-deficient TAMs vacate perivascular niches, reduce Procr+ endothelial progenitor populations, and normalize vascular permeability, collectively inducing tumor hypoxia and cancer cell death [59].